AHR AHR

Name: AHR Crucible Score
Creator: Kaladin Capital Intelligence

UnknownUnknownN/A📅 Scored April 5, 2026

Price at analysis: $48.09

Crucible Score

43.9

C-

Quality × Value Composite

KQI — Quality

54.0

Fundamental Quality Index

KVI — Value

31.6

D-

Valuation Attractiveness Index

Crucible Verdict — AHR

AHR trades near fair value at $48 versus a $49 base estimate, but the C- Crucible Score reflects serious underlying weaknesses. The company's 13% diversification score and dismal 13% earnings beat rate over recent quarters signal operational inconsistency and concentration risk. AHR needs to demonstrate more reliable execution before justifying any premium valuation.

— Kal, Kaladin Capital Intelligence

◆ KQI Quality Dimensions

Financial Quality

55.0

Growth Profile⚠

65.4

Moat Durability⚠

58.1

Management Effectiveness

49.7

Diversification & Resilience⚠

13.0

Market Position

58.0

Weakest dimension: Diversification & Resilience (13.0)

◆ KVI Value Dimensions

DCF Margin of Safety

48.0

FCF Yield & Cash Returns

21.1

Relative Valuation

43.7

Growth-Adjusted Value

17.3

Historical Valuation

9.5

Macro Context

16.1

◆ DCF Valuation Scenarios

Bear Case

$29.14

Base Case

$48.72

Bull Case

$74.58

Price at Analysis

$48.09

Scenario	Fair Value	Rev CAGR (5yr)	Terminal Margin	WACC
🔴 Bear	$29.14	6.0%	10.0%	10.2%
🟢 Base	$48.72	9.0%	12.0%	9.3%
🟢 Bull	$74.58	12.0%	14.0%	8.5%

Key Assumptions: AHR is a healthcare REIT with historically thin operating margins (4-11%) and negative net income, so FCF is driven primarily by EBITDA less capex with minimal taxes given REIT structure. Revenue CAGR over the trailing 5 years is approximately 15.6%, but growth is expected to moderate as the portfolio matures. Terminal operating margins are anchored near the 7-11% historical range with modest improvement reflecting scale benefits, while capex intensity is set at 5.5% of revenue consistent with the 5-6% historical average.

◆ Financial Snapshot

Profitability

Gross Margin15.2%

Operating Margin7.5%

Net Margin3.1%

ROIC13.1%

ROE-2.4%

Balance Sheet

Balance SheetCR: 0.00

Cash ConversionFCF/EPS: 3.24x

Capital IntensityCapex/Rev: 5.7%

Altman Z-Score2.78 (Grey)

Piotroski F-Score5/9 (Mixed)

Growth

Revenue CAGR13.5% CAGR

Earnings CAGR57.9% CAGR

Growth ConsistencyCV: 0.91

Segment BreadthInsufficient segments

Quarterly TrendMargin∆, Exp↓

Earnings CredibilityConsistent Misser

◆ Analyst Consensus & Leadership

Leadership & Governance

CEO Ownership< 1%

Compensation83% performance-based

Insider ActivitySelling

Capital AllocationROIC 13.1% vs WACC 4.3%

Earnings Beat Rate13% (4/18)

◆ Related Companies in Our Universe

Other Unknown companies scored by the Crucible:

ADBE81.8A-NICE80.7A-DECK79.9A-INTU79.9A-EXEL78.3A-MTCH78.2A-TTD78.0B+

Methodology All Scores Crucible Briefs Performance @KaladinCI

Analysis conducted April 5, 2026 based on most recent SEC filings. Updated quarterly, after new SEC filings.

Point-in-time fundamental analysis. Not investment advice. Scores reflect company quality and valuation at time of analysis and may not reflect current market conditions.